BGPT: Author Review: Liqin Wang

Explore by Goal

Quick Explanation Copied

Quick scientific read on “Liqin Wang”: From the evidence you provided (an OpenAlex author snapshot plus specific example papers), the work clusters strongly around cancer biology, drug resistance/targeted therapy, and cellular senescence, with at least one highly relevant high-throughput / translational base-editing study supported by genome-wide DNA off-target checks and RNA off-target analysis in mammalian systems ("Genome Biology" base-editing paper plus OpenAlex snapshot for author-level metrics).

Long Explanation

Author Review: Liqin Wang

Science-strength critique grounded in the evidence you supplied (OpenAlex author snapshot + provided paper-level raw extraction for one recent article).

1) What is actually known from the provided evidence

Author identity / bibliometric footprint: The supplied OpenAlex snapshot lists multiple “Liqin Wang” author records (different ORCIDs) and provides an aggregate view for the top match (e.g., works_count, cited_by_count, h_index, and top cited works). (OpenAlex data were included verbatim in your prompt; however, no DOI-based citations are possible for those OpenAlex metrics because DOI metadata was not provided for the author-level record.)
Example scientific contribution (recent, deep experimental evidence): The provided extraction for a Genome Biology article (“Efficient glycosylase-mediated base editing with minimal off-target effects in mammalian embryos”, 2025-10-21) reports genome-wide DNA and RNA off-target evaluation alongside on-target editing efficiency in mouse embryos and a sheep large-animal model, with data deposition to NCBI BioProjects (Off-target-aware base editing in embryos).
Example thematic footprint (from OpenAlex top works list provided): The snapshot’s top works include papers in Nature / Cell / Cell Reports and reviews in Nature Reviews Cancer, with topics such as melanoma, targeted therapies, senescence, and combination rationales (again: these topic assignments come from the provided OpenAlex record, not from DOI-cited full text in this message).

2) Visual evidence from the provided base-editing raw extraction

Below graphs summarize values you provided in the extracted “list_of_extracted_data” for DOI: 10.1186/s13059-025-03838-6.

Evidence-strength caution: these plots are not a full reconstruction of the article’s statistics; they summarize only the specific numeric snippets you supplied in the extraction. The underlying article’s full figures/tables could show wider distributions, confidence intervals, and per-locus variability that are not represented here (Use of extracted values only).

3) Scientific strength: what the evidence supports vs. what it doesn’t

Strengths consistent with high scientific practice

Specificity testing is multi-layered in the provided example: the paper description includes genome-wide DNA off-target assessment (GOTI analysis and WGS comparisons) and transcriptome-oriented RNA off-target evaluation, plus orthogonal assays. That approach directly targets the base-editing failure mode “silent” off-target outcomes (Genome-wide + RNA off-target framework).
Translational relevance via embryos and a large-animal model is claimed: mouse embryo editing plus Merino sheep embryo/fetal fibroblast editing for MSTN, including live-born lamb outcomes and WGS comparisons (Embryo + livestock model evidence).

Where the evidence is incomplete (known unknowns)

Detection-threshold limitations for ultra-rare events: even “genome-wide” sequencing does not guarantee perfect sensitivity for every class of off-target outcome; the excerpt itself flags sample-size and detection-threshold concerns for ultra-rare events (Explicit limits in extraction).
Cell-line RNA off-target context transfer: RNA off-target analysis in HEK293T may not reflect embryo-stage transcriptome dynamics. The extraction explicitly cautions species/tissue extrapolation (RNA off-target context caution).
Long-term phenotypic/safety evidence for edited animals is not fully established from the provided extraction: it points to the need for longer-term assessments in livestock (Long-term evidence gap).

Bias/interpretation risks to actively watch for

“Claim inflation” risk: statements like “minimal off-target effects” depend on thresholds, control selection, and statistical calling pipelines. The extraction lists many tools used for analysis, which is good for reproducibility, but it does not itself prove robustness to pipeline changes or show sensitivity analyses (Pipeline transparency vs. robustness unknowns).
Selective emphasis risk: provided extraction highlights key favorable results; it may omit full negative outcomes and variance structure. Full-text tables/figures are required for adjudicating effect distributions (Summary-excerpt limitation).

4) Scientific scope & likely skill signals (based on the provided author snapshot + example paper)

Evidence suggests competence in experimental biology plus computational analysis. The base-editing example explicitly integrates wet-lab embryo work, large-animal experimentation, and extensive variant-calling / sequence analysis tooling (Wet-lab + computational workflow).
Focus appears to be on clinically relevant molecular failure modes. The example emphasizes off-target fidelity, and the OpenAlex top-works list provided indicates drug resistance and senescence themes—however, in this response only the base-editing DOI is fully evidenced by extract details, so broader thematic claims cannot be upgraded to high-confidence without more full-text extractions (Evidence scope limitation).

5) Suggested next checks to improve confidence (what would disprove or change conclusions)

Recompute/verify off-target sensitivity using the deposited WGS and RNA-seq datasets (PRJNA1132788 and PRJNA1293385), with alternative variant-calling thresholds and replicate-level consistency tests; this would directly challenge “minimal off-target” conclusions if pipeline choices materially change results (Data deposition enabling re-analysis).
Validate biological consequences beyond early growth in sheep/lambs: if long-term phenotypes or additional tissues show subtle pathology or mosaicism inconsistent with “normal growth”, the translational confidence would drop (Long-term safety check needed).
Assess RNA off-target in embryo-relevant systems rather than primarily HEK293T: differences in transcript accessibility and repair context could change the RNA off-target landscape (Generalization gap for RNA).

Most important critical takeaway

The strongest part of the provided evidence is a fidelity-first experimental design for base editing—explicit genome-wide DNA off-target assessment plus RNA off-target checking, with dataset deposition enabling independent verification (Specificity + verifiability). However, the extracted record also flags limits (sample size, ultra-rare event sensitivity, RNA context transfer, and long-term safety/phenotypes), so confidence in “minimal off-target effects” should remain conditional until independent re-analysis and longer-term studies are evaluated (Conditional confidence).

Feedback:

Updated: May 02, 2026